Trond Williksen, CEO, and Septima Maguire, CFO of Benchmark Holdings (LON:BMK) hosted an Investor Presentation following publication of their Q2 / Interim results for the period to 31 March 2024.
Watch the full presentation for more details on period highlights, which included positive momentum in Genetics and Advanced Nutrition partially offset by Health and forex headwinds. Management provided a detailed update on operational performance per division, a Financial overview and an update on Outlook. Finally there was a Question & Answers session.
The video has been divided into chapters, as below:
0:00:03 Introduction
0:01:44 Overview of Q2 & period highlights
0:05:47 Operational Update - Genetics
0:16:00 Operational Update - Advanced Nutrition
0:20:55 Operational Update - Health
0:26:25 Financial Update
0:33:47 Outlook
0:36:36 Questions & Answers
Link to full video: https://www.equitydevelopment.co.uk/research/benchmark-holdings-investor-presentation-may-2024-q2-/-interim-results
About the Author
Equity Development
Equity Development Limited is regulated by the Financial Conduct Authority Disclaimer Equity Development Limited (‘ED’) is retained to act as financial adviser for its corporate clients, some or all of whom may now or in the future have an interest in the contents of this document. ED produces and distributes research for these corporate clients to persons who are not clients of ED. In the preparation of this report ED has taken professional efforts to ensure that the facts stated herein are clear, fair and not misleading, but makes no guarantee as to the accuracy or completeness of the information or opinions contained herein. This document has not been approved for the purposes of Section 21(2) of the Financial Services & Markets Act 2000 of the United Kingdom (‘FSMA’). Any reader of this research should not act or rely on this document or any of its contents. This report is being provided by ED to provide background information about the subject of the research to relevant persons, as defined by the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005. This document does not constitute, nor form part of, and should not be construed as, any offer for sale or purchase of (or solicitation of, or invitation to make any offer to buy or sell) any Securities (which may rise and fall in value). Nor shall it, or any part of it, form the basis of, or be relied on in connection with, any contract or commitment whatsoever. Research produced and distributed by ED on its client companies is normally commissioned and paid for by those companies themselves (‘issuer financed research’) and as such is not deemed to be independent as defined by the FCA but is ‘objective’ in that the authors are stating their own opinions. This document is prepared for clients under UK law. In the UK, companies quoted on AIM are subject to lighter due diligence than shares quoted on the main market and are therefore more likely to carry a higher degree of risk than main market companies. ED may in the future provide, or may have in the past provided, investment banking services to the subject of this report. ED, its Directors or persons connected may at some time in the future have, or have had in the past, a material investment in the Company. ED, its affiliates, officers, directors and employees, will not be liable for any loss or damage arising from any use of this document to the maximum extent that the law permits. More information is available on our website www.equitydevelopment.co.uk more »
0 comments
